NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Zealand Pharma A/S (PINK: ZLDPF)

 
ZLDPF Technical Analysis
4
As on 28th Mar 2025 ZLDPF STOCK Price closed @ 76.10 and we RECOMMEND Buy for LONG-TERM with Stoploss of 65.30 & Strong Buy for SHORT-TERM with Stoploss of 38.67 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ZLDPFSTOCK Price

Open 76.10 Change Price %
High 76.10 1 Day 0.00 0.00
Low 76.10 1 Week -8.40 -9.94
Close 76.10 1 Month -24.15 -24.09
Volume 5 1 Year 42.68 127.71
52 Week High 141.74 | 52 Week Low 33.42
 
PINK USA Most Active Stocks
TMSH 0.00 %
TXGE 3316.21 2.69%
QEDN 0.00 %
TWOH 0.00 %
GRLT 0.00 %
APLD 5.72 -6.23%
TGGI 0.00 %
HCMC 0.00 %
MDCE 0.00 %
CISO 0.45 -2.17%
 
PINK USA Top Gainers Stocks
ANAV 12.05 30025.00%
CGGYY 41.88 6765.57%
BKGM 950.00 6566.67%
GPGC 0.40 3900.00%
WRRZF 0.21 950.00%
NZERD 0.36 800.00%
MMCWF 0.07 600.00%
QTCI 0.12 500.00%
MYNDF 0.06 500.00%
ASCC 0.06 500.00%
 
PINK USA Top Losers Stocks
SKLV 0.06 -100.00%
SKLV 0.06 -100.00%
MVVYF 0.00 -100.00%
JNCCF 0.00 -100.00%
DKLRF 0.85 -100.00%
DKLRF 0.85 -100.00%
ATVVF 0.00 -100.00%
PCOGF 0.00 -100.00%
DBKSF 0.01 -96.77%
XTXXF 0.01 -95.45%
 
 
ZLDPF
Daily Charts
ZLDPF
Intraday Charts
Whats New @
Bazaartrend
ZLDPF
Free Analysis
 
ZLDPF Important Levels Intraday
RESISTANCE76.10
RESISTANCE76.10
RESISTANCE76.10
RESISTANCE76.10
RESISTANCE76.10
RESISTANCE76.10
RESISTANCE76.10
RESISTANCE76.10
 
ZLDPF Forecast March 2025
4th UP Forecast89.43
3rd UP Forecast85.16
2nd UP Forecast82.51
1st UP Forecast79.87
1st DOWN Forecast72.33
2nd DOWN Forecast69.69
3rd DOWN Forecast67.04
4th DOWN Forecast62.77
 
ZLDPF Weekly Forecast
4th UP Forecast76.10
3rd UP Forecast76.10
2nd UP Forecast76.10
1st UP Forecast76.10
1st DOWN Forecast76.10
2nd DOWN Forecast76.10
3rd DOWN Forecast76.10
4th DOWN Forecast76.10
 
ZLDPF Forecast2025
4th UP Forecast284.83
3rd UP Forecast217.89
2nd UP Forecast176.51
1st UP Forecast135.13
1st DOWN Forecast17.07
2nd DOWN Forecast-24.31
3rd DOWN Forecast-65.69
4th DOWN Forecast-132.63
 
 
ZLDPF Other Details
Segment EQ
Market Capital 1372448384.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ZLDPF Address
ZLDPF
 
ZLDPF Latest News
 
Your Comments and Response on Zealand Pharma A/S
 
ZLDPF Business Profile
Zealand Pharma A/S, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes Dasiglucagon single use syringe or autoinjector that has completed Phase III clinical trials for the treatment of severe hypoglycemia; Dasiglucagon dual-hormone artificial pancreas has completed Phase II clinical trials for automated diabetes management; Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism and in Phase II clinical trials for post bariatric surgery hypoglycemia. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion; and Beta Bionics, Inc. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. Address: Sydmarken 11, Copenhagen, Denmark, 2860
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service